Last reviewed · How we verify
NCT03816579: MAPP
A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism
NA trial testing PRO-A in Protein in 23 participants. Completed in 21 January 2021.
21 January 2021
Quick facts
| Lead sponsor | The University of Texas Medical Branch, Galveston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 26 March 2019 |
| Primary completion | 21 January 2021 |
| Estimated completion | 21 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PRO-A
- PRO-B
- PRO-C
Conditions studied
- Protein — all drugs for Protein →
- Diet — all drugs for Diet →
- Skeletal Muscle — all drugs for Skeletal Muscle →
Sponsor
The University of Texas Medical Branch, Galveston
Who can join
Adults 45 to 60, any sex, with Protein or Diet. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To highlight the importance of protein quality rather than the total protein content of a meal, the investigators will demonstrate that unlike high quality proteins, a single meal containing 30 g of an incomplete protein source does not stimulate skeletal muscle protein synthesis. Secondly, the investigators will directly challenge a prevalent, but untested, assertion that has the potential to negatively impact health. The goal is to demonstrate that complementary plant-proteins (i.e., two or more incomplete protein sources) must be consumed at the same meal to stimulate protein synthesis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Meals Containing Equivalent Total Protein from Foods Providing Complete, Complementary, or Incomplete Essential Amino Acid Profiles do not Differentially Affect 24-h Skeletal Muscle Protein Synthesis in Healthy, Middle-Aged Women.
Arentson-Lantz EJ, Von Ruff Z, Connolly G, Albano F, et al · · 2024 · cited 10× · PMID 39396760 · DOI 10.1016/j.tjnut.2024.10.010
Verify or expand the search:
- PubMed search for NCT03816579
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Protein
Currently open trials in the same condition.
- NCT06427018 — Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients · recruiting
- NCT05296096 — PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS · NA · recruiting
Other The University of Texas Medical Branch, Galveston trials
Trials by the same sponsor.
- NCT04095260 — Identification of Neuromusculoskeletal Variables Associated With Injury Risk and Performance in High School Athletes. · not yet recruiting
- NCT06800092 — Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment · Phase 2, PHASE3 · not yet recruiting
- NCT07337915 — Improving Sleep In Midlife Women · NA · recruiting
- NCT07203287 — Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease · Phase 4 · recruiting
- NCT07087743 — Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03816579 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Texas Medical Branch, Galveston
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03816579.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing